CHEYENNE JOHNSON: Open Payments
NPI 1023622412 · CARLISLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 34 payments from 10 companies in 2025. Trend: 2023 $638 · 2024 $648 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $172 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
| CSL Behring | 3 | $62 |
| PFIZER INC. | 3 | $54 |
| GENZYME CORPORATION | 2 | $45 |
| Genentech USA, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| Amgen Inc. | 1 | $18 |
Products named: NUCALA, DUPIXENT, FASENRA, Andembry, AIRSUPRA, ELIQUIS, Xolair, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
